Erschienen in:
01.02.2017 | Images That Teach
18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis
verfasst von:
Osamu Manabe, MD, PhD, Kenji Hirata, MD, PhD, Okamoto Shozo, MD, PhD, Tohru Shiga, MD, PhD, Yuko Uchiyama, MD, Kentaro Kobayashi, MD, PhD, Shiro Watanabe, MD, Takuya Toyonaga, MD, Hisaya Kikuchi, MD, Noriko Oyama-Manabe, MD, PhD, Nagara Tamaki, MD, PhD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 1/2017
Einloggen, um Zugang zu erhalten
Abstract
18F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.